FindTrial
Sign In

CONCEPTUAL AND CLINICAL EVALUATION OF RASAYANA CHIKITSA: ASSESSING THE IMMUNOMODULATORY POTENTIAL OF DHATRI TILADI YOGA IN HEALTHY INDIVIDUALS

CONCEPTUAL AND CLINICAL EVALUATION OF RASAYANA CHIKITSA: ASSESSING THE IMMUNOMODULATORY POTENTIAL OF DHATRI TILADI YOGA IN HEALTHY INDIVIDUALS - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/05/110869
Enrollment
30
Registered
2026-05-21
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Veera Monika Budhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: healthy individuals between 25-45 years

Exclusion criteria

Exclusion criteria: individuals with chronic/acute illness auto-immune diseases pregnant and lactating women recent usage of rasayana recently vaccinated

Design outcomes

Primary

MeasureTime frame
to assess immuno-globulin levels of Ig G, Ig A in a sample of 30 healthy individualsTimepoint: before and after—

Secondary

MeasureTime frame
to assess any differences in Ig G, Ig A levels of sample size of 30 healthy individualsTimepoint: after 60 days from the time of drug intervention—

Countries

India

Contacts

Public ContactMonika Budhi

sri venkateswawa ayurvedic college

kvenkatshivudu@gmail.com9441219398

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026